Open-label Extension Study to Evaluate the Long-term Safety and Tolerability of Dupilumab in Patients With Asthma Who Participated in a Previous Dupilumab Asthma Clinical Study

Trial Profile

Open-label Extension Study to Evaluate the Long-term Safety and Tolerability of Dupilumab in Patients With Asthma Who Participated in a Previous Dupilumab Asthma Clinical Study

Recruiting
Phase of Trial: Phase II/III

Latest Information Update: 14 Apr 2018

At a glance

  • Drugs Dupilumab (Primary)
  • Indications Asthma
  • Focus Adverse reactions
  • Acronyms LIBERTY ASTHMA TRAVERSE; TRAVERSE
  • Sponsors Sanofi
  • Most Recent Events

    • 08 Feb 2018 Planned End Date changed from 26 Sep 2019 to 1 Nov 2019.
    • 08 Feb 2018 Planned primary completion date changed from 26 Sep 2019 to 1 Nov 2019.
    • 24 Jan 2018 Planned End Date changed from 2 Oct 2019 to 26 Sep 2019.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top